Related Experiment Video
Updated: Mar 10, 2026

Development of Cell-type specific anti-HIV gp120 aptamers for siRNA delivery
Published on: June 23, 2011
Inhibition of HIV-1 Gag-membrane interactions by specific RNAs
Gabrielle C Todd1, Alice Duchon2, Jingga Inlora1
1Department of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA.
Abstract:
HIV-1 particle assembly, which occurs at the plasma membrane (PM) of cells, is driven by the viral polyprotein Gag. Gag recognizes phosphatidylinositol-(4,5)-bisphosphate [PI(4,5)P2], a PM-specific phospholipid, via the highly basic region (HBR) in its N-terminal matrix (MA) domain. The HBR is also known to bind to RNA. We have previously shown, using an in vitro liposome binding assay, that RNA inhibits Gag binding to membranes that lack PI(4,5)P2 If this RNA block is removed by RNase treatment, Gag can bind nonspecifically to other negatively charged membranes. In an effort to identify the RNA species that confer this inhibition of Gag membrane binding, we have tested the impact of purified RNAs on Gag interactions with negatively charged liposomes lacking PI(4,5)P2 We found that some tRNA species and RNAs containing stem-loop 1 of the psi region in the 5' untranslated region of the HIV-1 genome impose inhibition of Gag binding to membranes lacking PI(4,5)P2 In contrast, a specific subset of tRNAs, as well as an RNA sequence previously selected in vitro for MA binding, failed to suppress Gag-membrane interactions. Furthermore, switching the identity of charged residues in the HBR did not diminish the susceptibility of Gag-liposome binding for each of the RNAs tested, while deletion of most of the NC domain abrogates the inhibition of membrane binding mediated by the RNAs that are inhibitory to WT Gag-liposome binding. These results support a model in which NC facilitates binding of RNA to MA and thereby promotes RNA-based inhibition of Gag-membrane binding.
Insights
Specific RNAs, including some tRNAs and HIV-1 psi RNAs, inhibit HIV-1 Gag protein binding to cell membranes. This RNA-mediated inhibition is facilitated by the Gag NC domain, impacting viral assembly.
Area of Science:
- Virology
- Molecular Biology
- Biochemistry
Background:
- HIV-1 particle assembly is crucial for viral replication and occurs at the host cell's plasma membrane.
- The viral Gag polyprotein mediates assembly by binding to phosphatidylinositol-(4,5)-bisphosphate (PI(4,5)P2) via its matrix (MA) domain's highly basic region (HBR).
- The HBR also interacts with RNA, and RNA has been shown to inhibit Gag binding to membranes lacking PI(4,5)P2.
Purpose of the Study:
- To identify specific RNA species responsible for inhibiting HIV-1 Gag protein's interaction with negatively charged membranes.
- To elucidate the mechanism by which RNA influences Gag-membrane binding.
Main Methods:
- In vitro liposome binding assays were employed to test the effects of purified RNAs on Gag-liposome interactions.
- Various RNA species, including tRNAs and specific HIV-1 genomic fragments, were tested for their inhibitory capacity.
- Mutational analysis of the Gag protein (HBR and NC domain) was performed to assess their roles in RNA-mediated inhibition.
Main Results:
- Certain tRNA species and HIV-1 psi RNAs (stem-loop 1) significantly inhibited Gag binding to liposomes lacking PI(4,5)P2.
- A subset of tRNAs and an in vitro selected MA-binding RNA did not suppress Gag-membrane interactions.
- Deletion of the NC domain in Gag abrogated RNA-mediated inhibition, while mutations in the HBR did not affect susceptibility to RNA inhibition.
Conclusions:
- The Gag NC domain plays a critical role in facilitating RNA binding to the MA domain.
- This RNA-MA interaction, mediated by NC, leads to the inhibition of Gag binding to cellular membranes.
- These findings support a model where specific RNAs regulate HIV-1 Gag membrane association, potentially influencing viral assembly.
Related Concept Videos
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Experimental RNAi
Viruses with RNA Genomes
Retrovirus Life Cycles
Types of RNA
RNA Performs Diverse...

